{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "7", "safetyreportid": "21955998", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20251020", "reporttype": "2", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "1", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20230206", "receiptdateformat": "102", "receiptdate": "20250704", "fulfillexpeditecriteria": "1", "companynumb": "US-UCBSA-2023005636", "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "6", "senderorganization": "UCB" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "7", "patientonsetageunit": "801", "patientweight": "17.7", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Influenza", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Pyrexia", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Seizure", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Generalised tonic-clonic seizure", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Petit mal epilepsy", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Weight increased", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Dental caries", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Illness", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Chills", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.0", "reactionmeddrapt": "Feeling hot", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "1900248", "drugstructuredosagenumb": "2.2", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.2 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "drugindication": "Severe myoclonic epilepsy of infancy", "drugstartdateformat": "102", "drugstartdate": "20201113", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "1931543", "drugstructuredosagenumb": "2.4", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.4 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "drugindication": "Epilepsy", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "1931543", "drugstructuredosagenumb": "2.2", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.2 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugdosageform": "Oral solution", "drugstartdateformat": "102", "drugstartdate": "20230922", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "1973641", "drugstructuredosagenumb": "2.4", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.4 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "1973642", "drugstructuredosagenumb": "2.4", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.4 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "2027804", "drugstructuredosagenumb": "2.6", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.6 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugstructuredosagenumb": "12.8", "drugstructuredosageunit": "003", "drugdosageform": "Oral solution", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FINTEPLA", "drugbatchnumb": "2084835", "drugstructuredosagenumb": "2.9", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "2.9 MILLILITER, 2X/DAY (BID)", "drugdosageform": "Oral solution", "drugadministrationroute": "048", "actiondrug": "3", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "2", "medicinalproduct": "EPIDIOLEX", "drugstructuredosagenumb": "1.9", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "1.9 MILLILITER, 2X/DAY (BID)", "drugadministrationroute": "048", "drugindication": "Seizure", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CANNABIDIOL" }, "openfda": { "application_number": [ "NDA210365" ], "brand_name": [ "EPIDIOLEX" ], "generic_name": [ "CANNABIDIOL" ], "manufacturer_name": [ "Jazz Pharmaceuticals, Inc." ], "product_ndc": [ "70127-100" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CANNABIDIOL" ], "rxcui": [ "2058900", "2058906" ], "spl_id": [ "1eb7ac65-8df5-4a4a-9156-802cfaa92b06" ], "spl_set_id": [ "8bf27097-4870-43fb-94f0-f3d0871d1eec" ], "package_ndc": [ "70127-100-01", "70127-100-10", "70127-100-06", "70127-100-60" ], "nui": [ "M0003267", "N0000187062", "N0000185504", "N0000182140", "N0000191278", "N0000191273", "N0000182138", "N0000182139", "N0000187064" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]" ], "unii": [ "19GBJ60SN5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ONFI", "drugstructuredosagenumb": "3", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "3 MILLILITER, 2X/DAY (BID)", "drugadministrationroute": "048", "drugindication": "Seizure", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CLOBAZAM" }, "openfda": { "application_number": [ "NDA203993", "NDA202067" ], "brand_name": [ "ONFI" ], "generic_name": [ "CLOBAZAM" ], "manufacturer_name": [ "Lundbeck Pharmaceuticals LLC" ], "product_ndc": [ "67386-313", "67386-314", "67386-315" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLOBAZAM" ], "rxcui": [ "199450", "246172", "1191056", "1191058", "1366192", "1366196" ], "spl_id": [ "68dbe31c-2dbe-49ad-8b2e-2cf1b8521167" ], "spl_set_id": [ "de03bd69-2dca-459c-93b4-541fd3e9571c" ], "package_ndc": [ "67386-314-01", "67386-315-01", "67386-313-21" ], "nui": [ "N0000175694", "M0002356", "N0000182137", "N0000185506" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]" ], "unii": [ "2MRO291B4U" ] } } ], "summary": { "narrativeincludeclinical": "CASE EVENT DATE: 20230816" } } } ] }